Dr. Donald Sinclair Mccorquodale Iii is a Rockledge, Florida based neurologist with 13 years of experience in Neuromuscular Medicine. He completed his graduation from University Of Miami, Lm Miller School Of Medicine in 2011. He is also affiliated with hospitals like and . He accepts the Medicare-approved amount. Patients will not be billed for any more than the Medicare deductible and coinsurance. Active license number of Dr. Donald Sinclair Mccorquodale Iii is ME135837 for Neurology in Florida. His current practice location is 211 Coral Sands Dr Ste B, Rockledge. Patients can reach him at 321-345-6331 or can fax him at 321-345-3295. Dr. Donald Sinclair Mccorquodale Iii is MD/PHD in Neuromuscular Medicine and his NPI number (Unique professional ID assigned by NPPES) is 1285976332. Dr. Donald Sinclair Mccorquodale Iii is a neurologist or child neurologist who specializes in the diagnosis and management of disorders of nerve, muscle or neuromuscular junction, including amyotrophic lateral sclerosis, peripheral neuropathies (e.g., diabetic and immune mediated neuropathies), various muscular dystrophies, congenital and acquired myopathies, inflammatory myopathies (e.g., polymyositis, inclusion body myositis) and neuromuscular transmission disorders (e.g., myasthenia gravis, Lambert-Eaton myasthenic syndrome).
Complete Profile:
Dr. Donald Sinclair Mccorquodale Iii speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Dr. Donald Sinclair Mccorquodale Iii
Specialization:
Neuromuscular Medicine
Gender:
Male
Credentials:
MD/PHD
Experience:
13+ years
Medical School Attended:
University Of Miami, Lm Miller School Of Medicine
Graduation Year:
2011
Accepts Medicare Assignment:
Yes
Practice Address:
211 Coral Sands Dr Ste B, Rockledge, Florida, 32955-2749
Phone:
321-345-6331
Fax:
321-345-3295
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
5395068803
Enrollment ID:
I20180711002621
NPI Number:
1285976332
NPI Enumeration Date:
26 Mar, 2013
NPI Last Update On:
01 Sep, 2020
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Donald Sinclair Mccorquodale Iii are as mentioned below.
License Number
Specialization
State
Status
ME135837
Neurology
Florida
Primary
ME135837
Neuromuscular Medicine
Florida
Secondary
Student in an Organized Health Care Education/Training Program
Secondary
Hospital Affiliation:
Surgeons are affiliated to many hospitals whom they worked with in the past or are presently working with. One surgeon can be affiliated to four to five hospitals at a time.
Hospital Name (CCN)
State
Hospital Type
(100177)
Cocoa beach, FL
Acute Care Hospital
(100315)
Melbourne, FL
Acute Care Hospital
(100092)
Rockledge, FL
Acute Care Hospital
(100028)
Titusville, FL
Acute Care Hospital
Group Practice:
Group practices are practice of medicine by a group of physicians who share their premises and other resources. Following list states all the group name
with which Dr. Donald Sinclair Mccorquodale Iii is associated with along with the number of members in that group.
Organization Name (Group PAC ID)
Members
Knight Neurology Llc (5698916344)
5
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Dr. Donald Sinclair Mccorquodale Iii 211 Coral Sands Dr Ste B, Rockledge, Florida
Zip:
32955-2749
Phone Number:
321-345-6331
Patients can reach Dr. Donald Sinclair Mccorquodale Iii at 211 Coral Sands Dr Ste B, Rockledge, Florida or can call to book an appointment on 321-345-6331.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.